Severance and Change of Control Agreement Sample Contracts

Regency Centers Corp – 2017 AMENDED AND RESTATED SEVERANCE AND CHANGE OF CONTROL AGREEMENT (August 1st, 2019)

THIS AGREEMENT, effective as of the 22nd day of February, 2017, is by and between REGENCY CENTERS CORPORATION, a Florida corporation (the “Company”), Regency Centers, L.P., a Delaware limited partnership (the “Partnership”), and MICHAEL J. MAS (the “Employee”).

CytomX Therapeutics, Inc. – Amended and Restated Severance and Change of Control Agreement (May 9th, 2019)

This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of February 27, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Sean McCarthy, D. Phil. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of October 3, 2016 by and between the Company and Employee, as amended (the “Prior Agreement”).

CytomX Therapeutics, Inc. – Amended and Restated Severance and Change of Control Agreement (May 9th, 2019)

This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 25, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Rachel Humphrey, M.D. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of March 23, 2016 by and between the Company and Employee, as amended (the “Prior Agreement”).

CytomX Therapeutics, Inc. – Amended and Restated Severance and Change of Control Agreement (May 9th, 2019)

This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 25, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Debanjan Ray (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of May 15, 2017 by and between the Company and Employee, as amended (the “Prior Agreement”).

CytomX Therapeutics, Inc. – Amended and Restated Severance and Change of Control Agreement (May 9th, 2019)

This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 25, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and W. Michael Kavanaugh, M.D. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of March 23, 2016 by and between the Company and Employee, as amended (the “Prior Agreement”).

CytomX Therapeutics, Inc. – Amended and Restated Severance and Change of Control Agreement (May 9th, 2019)

This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 25, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Lloyd A. Rowland, Jr. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of May 16, 2018 by and between the Company and Employee, as amended (the “Prior Agreement”).

Stratus Properties Inc – Severance and Change of Control Agreement (March 18th, 2019)

This Severance and Change of Control Agreement (the “Agreement”) between Stratus Properties Inc., a Delaware corporation, and Erin D. Pickens (the “Executive”) is dated effective as of April 1, 2019 (the “Agreement Date”).

Stratus Properties Inc – Severance and Change of Control Agreement (March 18th, 2019)

This Severance and Change of Control Agreement (the “Agreement”) between Stratus Properties Inc., a Delaware corporation, and William H. Armstrong III (the “Executive”) is dated effective as of April 1, 2019 (the “Agreement Date”).

Adient Plc – KEY EXECUTIVE SEVERANCE AND CHANGE OF CONTROL AGREEMENT (September 13th, 2018)

THIS AGREEMENT (this “Agreement”), is made and entered into as of the 1st day of October, 2018 (the “Effective Date”), by and among Adient plc (along with any successor thereto, the “Company”), Adient US LLC (along with any successor thereto, the “Employer”) and Douglas DelGrosso (the “Executive”).

CytomX Therapeutics, Inc. – Severance and Change of Control Agreement (August 8th, 2018)

This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of May 16, 2018 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Lloyd Rowland (“Employee”).

On Semiconductor Corp – KEY OFFICER SEVERANCE AND CHANGE OF CONTROL AGREEMENT (February 21st, 2018)

This Key Officer Severance and Change of Control Agreement, dated as of June 1, 2017 (the “Agreement”), is made and entered into between Semiconductor Components Industries, LLC (the “Company”), with offices at 5005 East McDowell Road, Phoenix, Arizona 85008, and Taner Ozcelik (the “Executive”).

CytomX Therapeutics, Inc. – Severance and Change of Control Agreement (August 7th, 2017)

This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of May 15, 2017 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Debanjan Ray (“Employee”).

Innovative Industrial Properties Inc – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (June 8th, 2017)

THIS AGREEMENT, effective as of the 7th day of June, 2017, is by and between Innovative Industrial Properties, Inc., a Maryland corporation (the “Company”), IIP Operating Partnership, LP, a Delaware limited partnership (the “Partnership”), and Catherine Hastings (the “Employee”).

On Semiconductor Corp – KEY OFFICER SEVERANCE AND CHANGE OF CONTROL AGREEMENT (June 2nd, 2017)

This Key Officer Severance and Change of Control Agreement, dated as of June 1, 2017 (the “Agreement”), is made and entered into between Semiconductor Components Industries, LLC (the “Company”), with offices at 5005 East McDowell Road, Phoenix, Arizona 85008, and Mamoon Rashid (the “Executive”).

Regency Centers Lp – 2017 AMENDED AND RESTATED SEVERANCE AND CHANGE OF CONTROL AGREEMENT (May 10th, 2017)

THIS AGREEMENT, dated April 27, 2017, and effective as of the 14th day of March, 2017, is by and between REGENCY CENTERS CORPORATION, a Florida corporation (the “Company”), Regency Centers, L.P., a Delaware limited partnership (the “Partnership”), and MARTIN E. STEIN, JR. (the “Employee”).

Idera Pharmaceuticals, Inc. – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (May 4th, 2017)

CHANGE OF CONTROL AGREEMENT by and between Idera Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and < Name> (the "Executive"), dated as of <Date>.

SMART Global Holdings, Inc. – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (April 28th, 2017)

SEVERANCE AND CHANGE OF CONTROL AGREEMENT (“Agreement”), dated as of December 10, 2010 (the “Effective Date”) by and between SMART Modular Technologies (WWH), Inc. (the “Company”), and KiWan Kim (“Executive”).

Ingevity Corp – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (March 7th, 2017)

THIS SEVERANCE AND CHANGE OF CONTROL AGREEMENT (the “Agreement”) by and between Ingevity Corporation, a Delaware corporation (together with its Affiliated Companies, as hereinafter defined, being the “Company”), and John C. Fortson (the “Executive”) is dated as of the date set forth under the Company’s signature.

Ingevity Corp – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (March 7th, 2017)

THIS SEVERANCE AND CHANGE OF CONTROL AGREEMENT (the “Agreement”) by and between Ingevity Corporation, a Delaware corporation (together with its Affiliated Companies, as hereinafter defined, being the “Company”), and D. Michael Wilson (the “Executive”) is dated as the date set forth under the Company’s signature.

Ingevity Corp – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (March 7th, 2017)

THIS SEVERANCE AND CHANGE OF CONTROL AGREEMENT (the “Agreement”) by and between Ingevity Corporation, a Delaware corporation (together with its Affiliated Companies, as hereinafter defined, being the “Company”), and Katherine P. Burgeson (the “Executive”) is dated as of the date set forth under the Company’s signature.

Ingevity Corp – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (March 7th, 2017)

THIS SEVERANCE AND CHANGE OF CONTROL AGREEMENT (the “Agreement”) by and between Ingevity Corporation, a Delaware corporation (together with its Affiliated Companies, as hereinafter defined, being the “Company”), and S. Edward Woodcock (the “Executive”) is dated as of the date set forth under the Company’s signature.

SMART Global Holdings, Inc. – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (March 3rd, 2017)

SEVERANCE AND CHANGE OF CONTROL AGREEMENT (“Agreement”), dated as of December 10, 2010 (the “Effective Date”) by and between SMART Modular Technologies (WWH), Inc. (the “Company”), and Alan Marten (“Executive”).

SMART Global Holdings, Inc. – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (March 3rd, 2017)

SEVERANCE AND CHANGE OF CONTROL AGREEMENT (“Agreement”), dated as of December 10, 2010 (the “Effective Date”) by and between SMART Modular Technologies (WWH), Inc. (the “Company”), and Bruce Goldberg (“Executive”).

CytomX Therapeutics, Inc. – Severance and Change of Control Agreement (March 2nd, 2017)

This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Michael Kavanaugh, Senior Vice President, Chief Scientific Officer (“Employee”).

CytomX Therapeutics, Inc. – Severance and Change of Control Agreement (March 2nd, 2017)

This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Cynthia J. Ladd, Senior Vice President, General Counsel (“Employee”).

CytomX Therapeutics, Inc. – Amended and Restated Severance and Change of Control Agreement (March 2nd, 2017)

This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of October 3, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Sean McCarthy, D. Phil. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of April 1, 2015 by and between the Company and Employee, as amended (the “Prior Agreement”).

CytomX Therapeutics, Inc. – Severance and Change of Control Agreement (March 2nd, 2017)

This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Bob Goeltz, Senior Vice President, Chief Financial Officer (“Employee”).

On Semiconductor Corp – KEY OFFICER SEVERANCE AND CHANGE OF CONTROL AGREEMENT (February 28th, 2017)

This Key Officer Severance and Change of Control Agreement, dated as of November 17, 2016 (the “Agreement”), is made and entered into between Semiconductor Components Industries, LLC (the “Company”), with offices at 5005 East McDowell Road, Phoenix, Arizona 85008, and Taner Ozcelik (the “Executive”).

Innovative Industrial Properties Inc – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (January 24th, 2017)

THIS AGREEMENT, effective as of the 18th day of January, 2017, is by and between Innovative Industrial Properties, Inc., a Maryland corporation (the “Company”), IIP Operating Partnership, LP, a Delaware limited partnership (the “Partnership”), and Brian Wolfe (the “Employee”).

Innovative Industrial Properties Inc – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (January 24th, 2017)

THIS AGREEMENT, effective as of the 18th day of January, 2017, is by and between Innovative Industrial Properties, Inc., a Maryland corporation (the “Company”), IIP Operating Partnership, LP, a Delaware limited partnership (the “Partnership”), and Alan Gold (the “Employee”).

Innovative Industrial Properties Inc – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (January 24th, 2017)

THIS AGREEMENT, effective as of the 18th day of January, 2017, is by and between Innovative Industrial Properties, Inc., a Maryland corporation (the “Company”), IIP Operating Partnership, LP, a Delaware limited partnership (the “Partnership”), and Robert Sistek (the “Employee”).

Innovative Industrial Properties Inc – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (January 24th, 2017)

THIS AGREEMENT, effective as of the 18th day of January, 2017, is by and between Innovative Industrial Properties, Inc., a Maryland corporation (the “Company”), IIP Operating Partnership, LP, a Delaware limited partnership (the “Partnership”), and Paul Smithers (the “Employee”).

Adient Plc – KEY EXECUTIVE SEVERANCE AND CHANGE OF CONTROL AGREEMENT (January 20th, 2017)

THIS AGREEMENT (this “Agreement”), is made and entered into as of the ___ day of ______, 20__ (the “Effective Date”), by and among Adient plc (along with any successor thereto, the “Company”), Adient US LLC (along with any successor thereto, the “Employer”) and __________ (the “Executive”).

Innovative Industrial Properties Inc – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (October 17th, 2016)

THIS AGREEMENT, effective as of the _____ day of _______________, 2016, is by and between Innovative Industrial Properties, Inc., a Maryland corporation (the “Company”), IIP Operating Partnership, LP, a Delaware limited partnership (the “Partnership”), and Robert M. Sistek (the “Employee”).

Innovative Industrial Properties Inc – SEVERANCE AND CHANGE OF CONTROL AGREEMENT (October 17th, 2016)

THIS AGREEMENT, effective as of the _____ day of _______________, 2016, is by and between Innovative Industrial Properties, Inc., a Maryland corporation (the “Company”), IIP Operating Partnership, LP, a Delaware limited partnership (the “Partnership”), and Alan D. Gold (the “Employee”).